Transaction cost estimates for companies, projected from public filingsContent updated Oct 17, 2026 · Data checked Oct 29, 2026
Deal Cost Index M&A · IPO · Private capital · Chapter 11

M&A advisor fees · SEC filings 2023–2026

This page in other languages: Deutsch · Français · Español · Italiano · Nederlands · Polski · 简体中文 · 繁體中文 · 日本語 · 한국어

How much do M&A advisors charge?

Across 660 US merger proxies and tender-offer statements filed 2023–2026, target-side advisor fees fell from a median of 5.9% of deal value on deals under $50M to 0.9% on deals over $5B.

The fairness-opinion portion, paid when the opinion is delivered, had a median of $2.0M across 540 disclosures. Every fee below links to the sentence in the filing that states it.

Fees by deal size

In 114 disclosed deals valued $1–5B, target-side advisor fees had a median of 1.84% of deal value; in 19 deals under $50M the median was 5.90%, and in 58 deals above $5B it was 0.94% (SEC filings, 2023–2026).

Sum of every target-side advisor's fee in each deal, divided by deal value. Deal value is the aggregate consideration stated in the filing or, where none is stated, the cash price per share × shares outstanding. SPAC mergers and deals whose two value measures disagree by more than 2× are excluded.

Deal valueDealsMedian feeMedian % of valueMiddle halfMedian opinion fee
Under $50M19$1.66M5.90%2.83%–9.05%$575K
$50–100M22$2.5M3.44%1.25%–4.96%$1M
$100–250M30$3.95M2.27%1.46%–3.82%$1M
$250–500M39$9.8M2.92%1.75%–3.69%$1M
$500M–1B46$15.8M2.38%1.74%–2.98%$2M
$1–5B115$37M1.84%1.32%–2.30%$2.5M
$5B+58$89M0.94%0.58%–1.25%$4M

Fees by who hired the bank

Advisors hired by the target company had a median fee of 1.47% of deal value across 334 disclosures, on a median deal of $1.35B. Advisors to a special committee had a median of 0.76% across 31, on a median deal of $1.06B. Advisors to the acquirer had a median of 0.73% across 43, on a median deal of $1.2B. Deal sizes differ between these groups, so the size breakdown below is the fairer comparison.

One row per advisor fee. The first table covers every deal size; the second compares the same groups within each deal-size band. Groups with fewer than eight disclosures in a band are not given a median.

Who hired the bankDisclosed feesMedian feeMedian % of deal valueMedian deal value
The target company334$23.5M1.47%$1.35B
The target's board33$29.9M1.84%$1.78B
A special committee31$12.3M0.76%$1.06B
The acquirer43$9M0.73%$1.2B
Other parties5$5Mtoo few$101M
Who hired the bankUnder $250M$250M–1B$1–5B$5B+
The target company2.81%61 · median deal $99.3M2.24%79 · median deal $550M1.35%125 · median deal $2.14B0.67%69 · median deal $8.13B
The target's boardtoo few (4)3.25%9 · median deal $522M1.55%12 · median deal $2.07B0.60%8 · median deal $9.6B
A special committee2.17%9 · median deal $66.8Mtoo few (6)0.76%11 · median deal $2.52Btoo few (5)
The acquirer1.17%11 · median deal $105M1.11%9 · median deal $612M0.57%12 · median deal $1.71B0.26%11 · median deal $19B

Fees by bank tier and deal size

On sell-side deals valued $1–5B, a single bulge-bracket bank's fee had a median of 1.29% of deal value (80 disclosures), an elite boutique's 1.57% (44), and a middle-market bank's 1.16% (17).

A single bank’s fee on the sell side (target, target board or special committee), as a share of deal value, by the tier the bank is placed in on the public lists in the advisor directory. Each cell shows the median, the number of disclosures and the median deal value in that cell.

Bank tierUnder $250M$250M–1B$1–5B$5B+
Bulge brackettoo few (6)2.58%27 · median deal $574M1.29%80 · median deal $2.07B0.73%43 · median deal $7.89B
Elite boutique3.82%10 · median deal $119M2.75%30 · median deal $535M1.57%44 · median deal $2.3B0.64%25 · median deal $9.52B
Middle market2.96%28 · median deal $96.4M1.69%23 · median deal $486M1.16%17 · median deal $1.85Btoo few (6)
Not on a tier list2.48%33 · median deal $57.3M1.75%14 · median deal $496M1.27%8 · median deal $2.27B0.38%8 · median deal $9.56B

Fees by industry

Median combined sell-side advisor fee as a share of deal value, by the target's industry: Healthcare & life sciences, 2.45% across 130 deals (median deal $1.03B); Technology & telecom, 1.92% across 54 deals (median deal $1.45B); Industrials & business services, 1.78% across 53 deals (median deal $715M). Industries with smaller typical deals show higher percentages, so the columns on the right compare industries within the same deal size.

Combined fee of every sell-side advisor in each deal, as a share of deal value, by the target’s industry from its SEC standard industrial classification code. Industries with fewer than eight deals are not shown.

IndustryDealsMedian feeMedian % of valueMedian deal value% of value, Under $250M% of value, $250M–1B% of value, $1–5B% of value, $5B+
Healthcare & life sciences130$27.4M2.45%$1.03B3.87%31 · median deal $95.4M3.09%33 · median deal $522M2.29%41 · median deal $2.05B1.21%25 · median deal $9.02B
Technology & telecom54$29M1.92%$1.45B2.93%13 · median deal $45.4M2.61%9 · median deal $478M1.84%21 · median deal $2.05B0.64%11 · median deal $15.2B
Industrials & business services53$16.8M1.78%$715M1.98%13 · median deal $115M2.19%18 · median deal $519M1.75%16 · median deal $2.41Btoo few (6)
Consumer & retail37$24M1.54%$1.63Btoo few (6)1.95%10 · median deal $648M1.53%15 · median deal $2.29Btoo few (6)
Financial services25$13.5M1.11%$1.2Btoo few (3)too few (6)1.13%11 · median deal $1.51Btoo few (5)
Real estate19$23.8M1.96%$1.49Btoo few (2)too few (5)2.00%10 · median deal $1.56Btoo few (2)
Energy, mining & utilities9$32M1.13%$502Mtoo few (2)too few (3)too few (1)too few (3)

When the fee is paid

Beyond when the fee is paid, a filing may or may not mention a retainer, a tail period, an expense cap or an indemnity: how often proxies mention each term of the engagement, and what the opinion itself costs on the fairness opinion page. The published Lehman and double Lehman schedules are set against these disclosed fees on their own page, and M&A legal fees by deal size are on the legal page.

Where a filing states both, the fairness-opinion fee was a median 13.1% of the advisor's total fee (494 disclosures), usually paid when the opinion is delivered. A median 90.3% of the fee was payable only if the deal closed (502 disclosures), and in 104 of them the whole fee was.

Per advisor fee. The opinion fee is the part stated as payable on delivery of the fairness opinion. The part payable only on closing is shown only where the filing states it, or states the total and the other part of the fee; it is not estimated.

Deal valueMedian opinion feeOpinion fee as % of total feeShare payable only on closingWhole fee on closing
Under $250M$1M33.3%4683.3%5934%of 59
$250M–1B$1.63M12.7%8088.9%7614%of 76
$1–5B$2.25M8.7%11293.8%11523%of 115
$5B+$4M7.4%6594.5%5819%of 58

What the whole deal costs

In 41 US mergers whose proxy itemized the estimated fees and expenses of the deal, the total had a median of $13.7M. Financial advisory fees were a median 52% of that total, legal and accounting fees 41%, and printing, proxy solicitation and filing fees 1.7%. Where the deal value is known, total expenses were a median 2.97% of it (27 deals).

Some merger proxies, mostly for going-private and cash deals, print a table of the company’s estimated fees and expenses for the transaction. These are the 41 tables filed 2023–2026 whose items add up to their stated total. They are the company’s estimates at the time of the proxy and cover the company’s side only; the buyer’s own costs are not included. Where a proxy combines legal and accounting fees in one line, it is shown as legal.

CompanyDeal valueTotal expensesFinancial advisoryLegalAccountingPrinting and filingSource
Distribution Solutions Group, Inc.2026—$7.5M$4.27M$3Mwith accountingin legal$175KDEFM14AOct 2026
Bowhead Specialty Holdings Inc.2026$1.12B$20.1M1.80% of value$9.75M$10.1M—$311KDEFM14AOct 2026
Utz Brands, Inc.2026—$52M$42.5M$7.09M—$444KDEFM14AOct 2026
LogicMark, Inc.2026$1.18M$490K41.59% of value$210K$200Kwith accountingin legal$70KDEFM14AAug 2026
Electro Sensors Inc.2026—$586K$249K$274Kwith accountingin legal$34KDEFM14AJun 2026
KORE Group Holdings, Inc.2026$700M$11.8M1.69% of value$5.23M$4.03Mwith accountingin legal$75KDEFM14AJun 2026
Fonar Corp2026$66.8M$1.49M2.23% of value$120K$1.04Mwith accountingin legal$330KDEFM14AApr 2026
Clearwater Analytics Holdings, Inc.2026$7.89B$124M1.57% of value$106M$17Mwith accountingin legal$1.34MDEFM14AApr 2026
European Wax Center, Inc.2026—$17.3M$10.9M$6M$72K$287KDEFM14AApr 2026
Janus Henderson Group PLC2026$7.55B$140M1.86% of value$55.2M$83.7Mwith accountingin legal$1.46MDEFM14AMar 2026
Golden Entertainment, Inc.2026$72M$18.7M26.00% of value$10.5M$7.5Mwith accountingin legal$585KDEFM14AMar 2026
Guess Inc.2025—$24M$11.6M$11.5Mwith accountingin legal$440KDEFM14AOct 2025
Emeren Group Ltd2025—$1.66M$350K$963K—$100KDEFM14AOct 2025
AvidXchange Holdings, Inc.2025$2.34B$87.2M3.73% of value$62.3M$24.5Mwith accountingin legal$435KDEFM14AAug 2025
ESSA Pharma Inc.2025—$5.63M$2.65M$2.83Mwith accountingin legal$150KDEFM14AAug 2025
TaskUs, Inc.2025—$18.6M$12.6M$5.6Mwith accountingin legal$236KDEFM14AAug 2025
Walgreens Boots Alliance, Inc.2025$12.1B$150M1.24% of value$70M$45M$26.3M$4.44MDEFM14AJun 2025
Nordstrom Inc.2025$4.05B$66M1.63% of value$55M$9.3M—$984KDEFM14AApr 2025
Vacasa, Inc.2025$5,300$11.2M210396.98% of value$5.75M$5M$140K$261KDEFM14AMar 2025
Liberty TripAdvisor Holdings, Inc.2025—$5.4M$2M$2.78Mwith accountingin legal$516KDEFM14AMar 2025
VOXX International Corp2025$181M$6.27M3.46% of value$4.4M$1.7M$42K$82KDEFM14AMar 2025
Bally's Corp2024$650M$34.1M5.24% of value$14.7M$16.1Mwith accountingin legal$322KDEFM14AOct 2024
Arc Document Solutions, Inc.2024$162M$5.02M3.10% of value$1.5M$3M$50K$122KDEFM14AOct 2024
R1 RCM Inc. /DE2024$5.8B$149M2.56% of value$116M$25M$400K$780KDEFM14AOct 2024
Doma Holdings, Inc.2024$88.1M$13.9M15.77% of value$7.9M$5.4M$288K$64KDEFM14AJul 2024
Whole Earth Brands, Inc.2024$211M$14.3M6.77% of value$10.6M$3.5Mwith accountingin legal$164KDEFM14AJun 2024
HireRight Holdings Corp2024$876M$16.5M1.89% of value$10.6M$3.38M$1.43M$260KDEFM14AMay 2024
Fathom Digital Manufacturing Corp2024—$2.66M$700K$1.78M$148K$14KDEFM14AApr 2024
Via Renewables, Inc.2024—$2.14M$1.02M$900K—$114KDEFM14AMar 2024
Eargo, Inc.2024$52.9M$5.34M10.09% of value$2M$2.85M—$140KDEFM14AJan 2024
Consolidated Communications Holdings, Inc.2023$547M$29.6M5.40% of value$14.6M$14.4Mwith accountingin legal$183KDEFM14ADec 2023
Green Plains Partners LP2023$46.5M$5.16M11.10% of value$3.5M$1.4Mwith accountingin legal$223KDEFM14ADec 2023
Holly Energy Partners LP2023—$7.75M$3.75M$3.18Mwith accountingin legal$215KDEFM14AOct 2023
Paratek Pharmaceuticals, Inc.2023$462M$13.7M2.97% of value$9.26M$4M$100K$327KDEFM14AAug 2023
Franchise Group, Inc.2023$1.06B$15M1.42% of value$8.3M$6.5Mwith accountingin legal$158KDEFM14AJul 2023
Berkshire Grey, Inc.2023—$10.4M$6.71M$3.5Mwith accountingin legal$201KDEFM14AJun 2023
Focus Financial Partners Inc.2023$4.35B$50.7M1.17% of value$30.1M$18.1Mwith accountingin legal$718KDEFM14AJun 2023
Trean Insurance Group, Inc.2023$315M$2.87M0.91% of value$1.17M$1.37Mwith accountingin legal$136KDEFM14AMar 2023
AgroFresh Solutions, Inc.2023$161M$7.27M4.51% of value$4M$3.15Mwith accountingin legal$119KDEFM14AMar 2023
I-Minerals Inc2023—$120K$11K$96Kwith accountingin legal$8,000DEFM14AJan 2023
Myovant Sciences Ltd.2023$1.7B$48.8M2.87% of value$39.2M$8.95M$200K$415KDEFM14AJan 2023

Deals with more than one bank

72 of 329 deals (22%) had two or more sell-side banks. With one bank the combined fee had a median of 1.89% of deal value on a median deal of $818M; with two, 1.97% on a median deal of $2.47B.

Deals grouped by the number of banks advising the sell side that disclosed a fee. The combined fee is the sum of those banks’ fees.

Sell-side banksDealsMedian combined feeMedian % of valueMedian deal value
One257$17M1.89%$818M
Two70$57.2M1.97%$2.47B
Three or more2$148Mtoo few$39.8B

Fees by year

2023: 1.73% across 78 deals (median deal $944M); 2024: 1.84% across 75 deals (median deal $1.12B); 2025: 2.11% across 92 deals (median deal $945M); 2026: 1.87% across 84 deals (median deal $1.56B). Year-to-year movement mostly follows the mix of deal sizes filed that year, and 2026 covers filings through Oct 2026.

Year filedDealsMedian feeMedian % of valueMedian deal value
202378$19M1.73%$944M
202475$22.5M1.84%$1.12B
202592$26.1M2.11%$945M
202684$30.5M1.87%$1.56B

Fees by firm

Goldman Sachs disclosed 85 fees with a median of $35M (1.17% of deal value), Centerview Partners 81 with a median of $35M (1.75%), and J.P. Morgan 70 with a median of $24M (1.09%) in 2023–2026 SEC filings. By tier, a single elite-boutique advisor's fee had a median of 1.75% of deal value across 109 disclosures, against 1.21% across 155 for bulge-bracket banks.

Firms with two or more disclosed fees. Tier follows the public lists described in the advisor directory; a firm is placed on the first list it appears on.

FirmTierFee disclosuresMedian feeMedian % of valueMedian opinion fee
Goldman SachsBulge bracket85$35M1.17%$2M
Centerview PartnersElite boutique82$34.7M1.75%$2M
J.P. MorganBulge bracket71$23M1.09%$3M
BofA SecuritiesBulge bracket51$18M1.07%$2M
Morgan StanleyBulge bracket44$34M1.50%$4.5M
JefferiesMiddle market35$18.5M1.45%$2M
CitiBulge bracket24$20.5M1.42%$2.5M
EvercoreElite boutique23$20M1.55%$2M
Leerink PartnersNot on a tier list22$3M2.62%$1M
Houlihan LokeyMiddle market21$2.2M1.61%$875K
TD CowenMiddle market18$3.25M3.82%$1M
LazardElite boutique16$20M1.60%$2M
Wells Fargo SecuritiesNot on a tier list15$15.7M1.02%$3.5M
Piper SandlerMiddle market13$3M2.17%$875K
Guggenheim SecuritiesElite boutique13$11.2M1.12%$2.25M
PJT PartnersElite boutique13$26.2M0.80%$5M
Keefe, Bruyette & WoodsNot on a tier list9$4.5M1.21%$1M
Perella Weinberg PartnersElite boutique9$6M2.12%$2M
KrollMiddle market9$575K0.43%$243K
Truist SecuritiesMiddle market8$7.7M1.75%$1M
Raymond JamesMiddle market7$2.25M1.26%$350K
NewbridgeNot on a tier list7$75K—$45K
Moelis & CompanyElite boutique6$19.5M2.06%$2.25M
Allen & CompanyNot on a tier list6$37.5M0.13%$7.75M
William BlairMiddle market5$1M0.62%$1M
BMONot on a tier list5$17.2M—$3M
RothschildElite boutique5$14.3M1.77%$2.75M
StifelMiddle market4$1.75M5.88%$1.5M
UBSBulge bracket4$18.3M4.66%$2.5M
Roth Capital PartnersNot on a tier list4$230K17.82%$263K
ChestnutNot on a tier list3$4M0.35%—
RBC Capital MarketsNot on a tier list3$10M0.20%$1.5M
Craig-HallumNot on a tier list3$500K3.70%$300K
BTIGNot on a tier list3$1.5M0.92%$500K
ChardanNot on a tier list3$6.81M11.35%—
RBCCMNot on a tier list3$4M1.70%$4.5M
FTNot on a tier list3$11.3M2.06%$1.13M
ScalarNot on a tier list2$118K—$85K
Deutsche BankBulge bracket2$18.5M1.11%$1.5M
IntrinsicNot on a tier list2$200K0.20%—
BarclaysBulge bracket2$45.5M0.77%$3M
CohenNot on a tier list2$3.75M0.83%$500K
MTSNot on a tier list2$2.5M—$2.5M
ArdeaNot on a tier list2$26.3M1.13%—
Gordon DyalNot on a tier list2$45M——
SantanderNot on a tier list2$5M——
LincolnMiddle market2$1.4M——
Qatalyst PartnersElite boutique2$83.5M0.51%$6.25M
IBI Corporate FinanceNot on a tier list2$435K2.72%—
FocusLower middle market2$880K2.93%—
IntrepidNot on a tier list2$250K0.15%$875K
StephensMiddle market2$6.25M0.70%—
MacquarieNot on a tier list2$9.8M1.63%$1.25M
KidronNot on a tier list2$275K4.74%$150K
SolomonNot on a tier list0——$2.25M
Robert W. BairdMiddle market2$12.8M—$1.5M
LionTreeNot on a tier list2$31.5M—$8M
JLLNot on a tier list2$3.33M0.80%$400K

Bank profiles

Each of the 27 banks with five or more disclosed fees, with the medians for its own engagements and its most recent engagements, each linked to the filing it comes from. Each profile has its own link; every engagement is in the full table at the end of the page.

Goldman Sachs

Goldman Sachs disclosed 85 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (74 for the sell side, 11 for the acquirer), with a median fee of $35M; where deal value is known, the median was 1.17% of deal value across 53 deals, on a median deal of $2.98B.

  • Tier: Bulge bracket
  • Median fairness-opinion fee: $2M (15 disclosures)
  • Share of the fee payable only on closing: median 100% (61 disclosures)
  • Industries: Healthcare & life sciences (24), Industrials & business services (18), Consumer & retail (11)
  • Largest disclosed fee: $117M, advising the target company on Karuna Therapeutics, Inc. (2024) DEFM14AFeb 2024

The 8 most recent of 85 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
CBIZ, Inc.acquired by Grant Thorntontarget company$2.98B$53M1.78%DEFM14ASep 2026
Integer Holdings Corpacquired by Kkrtarget company$4.32B$85.7M1.99%DEFM14ASep 2026
BIO-TECHNE Corptarget company$11.3B$106M0.94%DEFM14AAug 2026
Dominion Energy, Inc.acquired by NextEra Energytarget company—$47M—DEFM14AJul 2026
Avalonbay Communities Inc.acquired by Equity Residentialtarget company$24.7B$65M0.26%DEFM14AJul 2026
Apogee Therapeutics, Inc.acquired by AbbVietarget company$10B$65M0.65%DEFM14AJul 2026
Corebridge Financial, Inc.acquired by Equitable Holdings, Inc.acquirer—$50M—DEFM14AJun 2026
Equitable Holdings, Inc.acquired by Corebridge Financial, Inc.target company—$50M—DEFM14AJun 2026

Centerview Partners

Centerview Partners disclosed 82 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (78 for the sell side, 4 for the acquirer), with a median fee of $34.7M; where deal value is known, the median was 1.75% of deal value across 67 deals, on a median deal of $1.91B.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $2M (80 disclosures)
  • Share of the fee payable only on closing: median 94.2% (74 disclosures)
  • Industries: Healthcare & life sciences (60), Technology & telecom (10), Consumer & retail (4)
  • Largest disclosed fee: $113M, advising the target's board on Verona Pharma plc (2025) DEFM14AAug 2025

The 8 most recent of 82 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Personalisacquired by Tempus AItarget company—$29.4M—DEFM14AOct 2026
Biolife Solutions Inc.acquired by Repligentarget company$1.58B$25M—DEFM14ASep 2026
Nuvalent, Inc.target company$10.6B$100M0.94%SC 14D9Jun 2026
Esperion Therapeutics, Inc.target company$703M$37.5M5.34%DEFM14AJun 2026
KalVista Pharmaceuticals, Inc.target company$1.08B$44M4.09%SC 14D9May 2026
Centessa Pharmaceuticals plcacquired by Lillytarget company—$66M—DEFM14AMay 2026
Soleno Therapeutics Inc.target company$4.44B$40M0.90%SC 14D9Apr 2026
Terns Pharmaceuticals, Inc.acquired by Mercktarget company$6.69B$50.5M0.75%SC 14D9Apr 2026

J.P. Morgan

J.P. Morgan disclosed 71 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (55 for the sell side, 16 for the acquirer), with a median fee of $23M; where deal value is known, the median was 1.09% of deal value across 43 deals, on a median deal of $2.14B.

  • Tier: Bulge bracket
  • Median fairness-opinion fee: $3M (59 disclosures)
  • Share of the fee payable only on closing: median 88.9% (49 disclosures)
  • Industries: Technology & telecom (17), Industrials & business services (15), Healthcare & life sciences (13)
  • Largest disclosed fee: $90M, advising the target company on Warner Bros. Discovery, Inc. (2026) DEFM14AMar 2026

The 8 most recent of 71 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
LCI Industriesacquired by Patrick Industriesacquirer—$20M—DEFM14AOct 2026
Marketaxess Holdings Inc.target company$5.88B$65.5M1.11%DEFM14ASep 2026
ACV Auctions Inc.acquired by Coparttarget company$1.78B$26M1.46%SC 14D9Sep 2026
Atkore Inc.acquired by Prysmiantarget company$2.6B$21.5M0.83%DEFM14ASep 2026
Crinetics Pharmaceuticals, Inc.target company$9.02B$69.4M0.77%DEFM14AJul 2026
Dominion Energy, Inc.acquired by NextEra Energytarget company—$78M—DEFM14AJul 2026
Avanos Medical, Inc.acquired by Aiptarget company$4.13M$20M—DEFM14AJun 2026
Catalyst Pharmaceuticals, Inc.target company$3.86B$61M1.58%DEFM14AJun 2026

BofA Securities

BofA Securities disclosed 51 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (45 for the sell side, 6 for the acquirer), with a median fee of $18M; where deal value is known, the median was 1.07% of deal value across 34 deals, on a median deal of $1.61B.

  • Tier: Bulge bracket
  • Median fairness-opinion fee: $2M (41 disclosures)
  • Share of the fee payable only on closing: median 88.9% (33 disclosures)
  • Industries: Industrials & business services (13), Real estate (11), Healthcare & life sciences (9)
  • Largest disclosed fee: $130M, advising the target company on Norfolk Southern Corporation (2025) DEFM14AOct 2025

The 8 most recent of 51 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Bowman Consulting Group Ltd.acquired by Bernhardtarget company$573M$14.8M2.58%DEFM14AOct 2026
LXP Industrial Trusttarget company$3.61B$13M0.36%DEFM14ASep 2026
Gran Tierra Energy Inc.acquired by Maurel & Promtarget company—$10M—DEFM14ASep 2026
Dominion Energy, Inc.acquired by NextEra Energyacquirer—$30M—DEFM14AJul 2026
Cross Country Healthcare Inc.target company$428M$6.12M1.43%DEFM14AJun 2026
Sila Realty Trust, Inc.acquired by Blue Owltarget company$1.57B$24.9M1.58%DEFM14AMay 2026
Whitestone REITtarget company$781M$17.5M2.24%DEFM14AMay 2026
ENVIRI Corpacquired by Veoliatarget company$3.04B$46M—DEFM14AApr 2026

Morgan Stanley

Morgan Stanley disclosed 44 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (38 for the sell side, 6 for the acquirer), with a median fee of $34M; where deal value is known, the median was 1.50% of deal value across 24 deals, on a median deal of $2.2B.

  • Tier: Bulge bracket
  • Median fairness-opinion fee: $4M (38 disclosures)
  • Share of the fee payable only on closing: median 89.5% (25 disclosures)
  • Industries: Technology & telecom (10), Industrials & business services (10), Real estate (7)
  • Largest disclosed fee: $84M, advising the target company on Confluent, Inc. (2026) DEFM14AJan 2026

The 8 most recent of 44 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Personalisacquired by Tempus AIacquirer—$15M—DEFM14AOct 2026
Lantheus Holdings, Inc.acquired by CapVesttarget company$6.69B$81M1.21%DEFM14ASep 2026
Simulations Plus, Inc.target company$375M$11M2.93%DEFM14AJul 2026
Avalonbay Communities Inc.acquired by Equity Residentialacquirer$24.7B$50M0.20%DEFM14AJul 2026
Huntsman CORPacquired by Olintarget company—$9M—DEFM14AJul 2026
Corebridge Financial, Inc.acquired by Equitable Holdings, Inc.target company—$60M—DEFM14AJun 2026
Equitable Holdings, Inc.acquired by Corebridge Financial, Inc.acquirer—$60M—DEFM14AJun 2026
Organon & Co.acquired by Sun Pharmatarget company$3.68B$39.4M1.07%DEFM14AJun 2026

Jefferies

Jefferies disclosed 35 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (34 for the sell side, 1 for the acquirer), with a median fee of $18.5M; where deal value is known, the median was 1.45% of deal value across 32 deals, on a median deal of $1.2B.

  • Tier: Middle market
  • Median fairness-opinion fee: $2M (28 disclosures)
  • Share of the fee payable only on closing: median 90.0% (25 disclosures)
  • Industries: Healthcare & life sciences (14), Consumer & retail (8), Financial services (4)
  • Largest disclosed fee: $90M, advising the target company on Merus N.V. (2025) SC 14D9Oct 2025

The 8 most recent of 35 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Weave Communications, Inc.acquired by Francisco Partnerstarget company$762M$15.9M2.09%DEFM14ASep 2026
Nathans Famous, Inc.target company$418M$9.6M2.30%DEFM14ASep 2026
Safety Insurance Group Inc.acquired by Mapfretarget company$1.51B$17.5M1.16%DEFM14ASep 2026
Supernus Pharmaceuticals, Inc.acquired by Indivioracquirer—$27.5M—DEFM14ASep 2026
Apogee Therapeutics, Inc.acquired by AbbVietarget company$10B$65M0.65%DEFM14AJul 2026
KalVista Pharmaceuticals, Inc.target company$1.08B$29.7M2.76%SC 14D9May 2026
Centessa Pharmaceuticals plcacquired by Lillytarget company—$27.6M—DEFM14AMay 2026
Terns Pharmaceuticals, Inc.acquired by Mercktarget company$6.69B$37M0.55%SC 14D9Apr 2026

Citi

Citi disclosed 24 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (20 for the sell side, 4 for the acquirer), with a median fee of $20.5M; where deal value is known, the median was 1.42% of deal value across 13 deals, on a median deal of $1.74B.

  • Tier: Bulge bracket
  • Median fairness-opinion fee: $2.5M (19 disclosures)
  • Share of the fee payable only on closing: median 89.0% (18 disclosures)
  • Industries: Technology & telecom (6), Energy, mining & utilities (5), Real estate (4)
  • Largest disclosed fee: $73M, advising the target company on Mr. Cooper Group Inc. (2025) DEFM14AJul 2025

The 8 most recent of 24 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Novagold Resources Inc.target company—$11.5M—DEFM14AOct 2026
Atkore Inc.acquired by Prysmiantarget company$2.6B$38M1.46%DEFM14ASep 2026
Huntsman CORPacquired by Olintarget company—$21M—DEFM14AJul 2026
Green Dot Corptarget company—$13M—DEFM14AMay 2026
Thermon Group Holdings, Inc.acquired by Cecoacquirer$2.1B$17.5M0.83%DEFM14AApr 2026
Jamf Holding Corp.acquired by Francisco Partnerstarget company$1.74B$32M1.84%DEFM14ADec 2025
STAAR Surgical Companyacquired by Alcontarget's board$1.39B$30.6M2.21%DEFM14ASep 2025
Aris Water Solutions, Inc.acquired by Westarget company—$20M—DEFM14ASep 2025

Evercore

Evercore disclosed 23 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (17 for the sell side, 6 for the acquirer), with a median fee of $20M; where deal value is known, the median was 1.55% of deal value across 16 deals, on a median deal of $2B.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $2M (17 disclosures)
  • Share of the fee payable only on closing: median 93.0% (21 disclosures)
  • Industries: Industrials & business services (6), Technology & telecom (4), Energy, mining & utilities (4)
  • Largest disclosed fee: $94M, advising the target company on Cidara Therapeutics, Inc. (2025) SC 14D9Dec 2025

The 8 most recent of 23 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Varex Imaging Corpacquired by Teledynetarget company$695M$36.4M5.24%DEFM14ASep 2026
Trico Bancshares /acquired by First Hawaiianacquirer—$19M—DEFM14ASep 2026
Apellis Pharmaceuticals, Inc.acquired by Biogentarget company$3.96B$76M1.92%SC 14D9Apr 2026
Calavo Growers, Inc.acquired by Mission Produceacquirer$486M$6.5M1.34%DEFM14AMar 2026
Civitas Resources, Inc.acquired by SM Energyacquirer—$20M—DEFM14ADec 2025
Warner Bros. Discovery, Inc.acquired by Netflixtarget company$74.3B$55M0.07%SC 14D9Dec 2025
Cidara Therapeutics, Inc.acquired by Mercktarget company$6.96B$94M1.35%SC 14D9Dec 2025
Hanesbrands Inc.acquired by Gildantarget company—$4.5M—DEFM14AOct 2025

Leerink Partners

Leerink Partners disclosed 22 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (21 for the sell side, 1 for the acquirer), with a median fee of $3M; where deal value is known, the median was 2.62% of deal value across 16 deals, on a median deal of $123M.

  • Tier: Not on a tier list
  • Median fairness-opinion fee: $1M (21 disclosures)
  • Share of the fee payable only on closing: median 66.7% (17 disclosures)
  • Industries: Healthcare & life sciences (22)
  • Largest disclosed fee: $60.8M, advising the target company on Crinetics Pharmaceuticals, Inc. (2026) DEFM14AJul 2026

The 8 most recent of 22 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Crinetics Pharmaceuticals, Inc.target company$9.02B$60.8M0.67%DEFM14AJul 2026
XOMA Royalty Corptarget company$489M$18.4M3.76%DEFM14AJun 2026
Repare Therapeutics Inc.target company—$4M—DEFM14ADec 2025
scPharmaceuticals Inc.target company$285M$8.8M3.09%SC 14D9Sep 2025
Tourmaline Bio, Inc.acquired by Novartistarget company$1.23B$30.8M2.50%SC 14D9Sep 2025
scPharmaceuticals Inc.target's board$285M$8.8M3.09%SC 14D9Sep 2025
LAVA Therapeutics NVacquired by Xomatarget company—$3M—DEFM14ASep 2025
HilleVax, Inc.target company$97.8M$3M3.07%SC 14D9Aug 2025

Houlihan Lokey

Houlihan Lokey disclosed 21 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (21 for the sell side, 0 for the acquirer), with a median fee of $2.2M; where deal value is known, the median was 1.61% of deal value across 11 deals, on a median deal of $191M.

  • Tier: Middle market
  • Median fairness-opinion fee: $875K (14 disclosures)
  • Share of the fee payable only on closing: median 79.1% (8 disclosures)
  • Industries: Industrials & business services (5), Financial services (4), Consumer & retail (4)
  • Largest disclosed fee: $15M, advising the target company on Vital Energy, Inc. (2025) DEFM14ANov 2025

The 8 most recent of 21 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Liveperson Inc.acquired by SoundHoundtarget company—$1.5M—DEFM14AJul 2026
Forian Inc.special committee$65.5M$2.5M3.81%SC 14D9Apr 2026
Monroe Capital Corporationspecial committee—$1.75M—DEFM14AJan 2026
Vital Energy, Inc.acquired by Crescenttarget company—$15M—DEFM14ANov 2025
Bgsf, Inc.acquired by A&M Capital Advisorstarget company—$2.2M—DEFM14AJul 2025
Servotronics Inc /DE/target company$98.4M$8.5M8.64%SC 14D9Jun 2025
Intevac, Inc.acquired by Seagate Technologytarget company—$2.4M—SC 14D9Mar 2025
Lionsgate Studios Corp.special committee—$1M—DEFM14AMar 2025

TD Cowen

TD Cowen disclosed 18 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (15 for the sell side, 3 for the acquirer), with a median fee of $3.25M; where deal value is known, the median was 3.82% of deal value across 8 deals, on a median deal of $100M.

  • Tier: Middle market
  • Median fairness-opinion fee: $1M (5 disclosures)
  • Share of the fee payable only on closing: median 83.0% (17 disclosures)
  • Industries: Healthcare & life sciences (10), Energy, mining & utilities (3), Industrials & business services (2)
  • Largest disclosed fee: $15M, advising the target company on Personalis (2026) DEFM14AOct 2026

The 8 most recent of 18 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Personalisacquired by Tempus AItarget company—$15M—DEFM14AOct 2026
KORE Group Holdings, Inc.acquired by Searchlightacquirer$700M$6M—DEFM14AJun 2026
Allbirds, Inc.acquired by American Exchange Grouptarget company$39M$2M5.13%DEFM14AMay 2026
Kezar Life Sciences, Inc.target company$51.3M$2.5M4.88%SC 14D9Apr 2026
Generation Bio Co.target company—$1.6M—SC 14D9Jan 2026
Generation Bio Co.target company—$1.6M—SC 14D9Jan 2026
Synchronoss Technologies, Inc.acquired by Lumine Grouptarget company$104M$4.7M4.54%DEFM14AJan 2026
Mersana Therapeutics, Inc.target company—$3.5M—SC 14D9Dec 2025

Lazard

Lazard disclosed 16 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (11 for the sell side, 5 for the acquirer), with a median fee of $20M; where deal value is known, the median was 1.60% of deal value across 8 deals, on a median deal of $826M.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $2.5M (12 disclosures)
  • Share of the fee payable only on closing: median 88.7% (10 disclosures)
  • Industries: Healthcare & life sciences (7), Industrials & business services (3), Energy, mining & utilities (2)
  • Largest disclosed fee: $70M, advising the acquirer on Dominion Energy, Inc. (2026) DEFM14AJul 2026

The 8 most recent of 16 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Theravance Biopharma, Inc.target company$883M$23M2.61%DEFM14AAug 2026
Dominion Energy, Inc.acquired by NextEra Energyacquirer—$70M—DEFM14AJul 2026
Huntsman CORPacquired by Olinacquirer—$24M—DEFM14AJul 2026
SunOpta Inc.target company$769M$17M2.21%DEFM14AMar 2026
Bridge Investment Group Holdings Inc.acquired by Apollo Global Managementspecial committee—$9M—DEFM14AMay 2025
Endo, Inc.acquired by Mallinckrodt plcacquirer$80.1M$35M—DEFM14AMay 2025
Logility Supply Chain Solutions, Incacquired by Apteantarget company$478M$9.8M2.05%DEFM14AMar 2025
Berry Global Group, Inc.acquired by Amcortarget company—$43.5M—DEFM14AJan 2025

Wells Fargo Securities

Wells Fargo Securities disclosed 15 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (11 for the sell side, 4 for the acquirer), with a median fee of $15.7M; where deal value is known, the median was 1.02% of deal value across 11 deals, on a median deal of $2.21B.

  • Tier: Not on a tier list
  • Median fairness-opinion fee: $3.5M (6 disclosures)
  • Share of the fee payable only on closing: median 84.6% (10 disclosures)
  • Industries: Industrials & business services (4), Real estate (3), Energy, mining & utilities (3)
  • Largest disclosed fee: $59M, advising the target company on Life Storage, Inc. (2023) DEFM14AJun 2023

The 8 most recent of 15 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Greenbacker Renewable Energytarget company$375M$7M1.87%DEFM14AOct 2026
Select Medical Holdings Corpacquired by Wcasacquirer$2.05B$11.5M0.56%DEFM14AMay 2026
Aes Corptarget company$502M$15M2.99%DEFM14AMay 2026
Talkspace, Inc.acquired by Uhstarget company$710M$15.7M2.21%DEFM14AApr 2026
Marine Products Corporationacquired by MasterCraftacquirer$85.6M$4.25M4.96%DEFM14AApr 2026
Brighthouse Financial, Inc.acquired by Aquariantarget company$4B$41M1.02%DEFM14AJan 2026
Norfolk Southern Corporationacquired by Union Pacificacquirer$20B$52.5M0.26%DEFM14AOct 2025
Chart Industries, Inc.acquired by Baker Hughestarget's board$10.1B$55.8M0.55%DEFM14ASep 2025

Guggenheim Securities

Guggenheim Securities disclosed 13 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (10 for the sell side, 3 for the acquirer), with a median fee of $11.2M; where deal value is known, the median was 1.12% of deal value across 9 deals, on a median deal of $1.71B.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $2.5M (3 disclosures)
  • Share of the fee payable only on closing: median 100% (6 disclosures)
  • Industries: Healthcare & life sciences (7), Energy, mining & utilities (3), Consumer & retail (2)
  • Largest disclosed fee: $45M, advising the target company on Patterson Companies, Inc. (2025) DEFM14AFeb 2025

The 8 most recent of 13 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Soleno Therapeutics Inc.target company$4.44B$33M0.74%SC 14D9Apr 2026
Berry Corpacquired by Crctarget company—$11M—DEFM14ANov 2025
Metsera, Inc.acquired by Pfizertarget company$5.25B$30M0.57%DEFM14AOct 2025
Verve Therapeutics, Inc.acquired by Eli Lilly and Companytarget company$267M$11.2M4.19%SC 14D9Jun 2025
ACELYRIN, Inc.acquired by Alumis Inc.target company$101M$5.5M5.46%DEFM14AApr 2025
Patterson Companies, Inc.target company$3.01B$45M1.50%DEFM14AFeb 2025
G1 Therapeutics, Inc.target company$259M$2M0.77%SC 14D9Aug 2024
Diamond Offshore Drilling, Inc.acquired by Nobletarget company$2.2B$11M—DEFM14AJul 2024

Piper Sandler

Piper Sandler disclosed 13 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (10 for the sell side, 3 for the acquirer), with a median fee of $3M; where deal value is known, the median was 2.17% of deal value across 7 deals, on a median deal of $89.1M.

  • Tier: Middle market
  • Median fairness-opinion fee: $750K (10 disclosures)
  • Share of the fee payable only on closing: median 88.6% (10 disclosures)
  • Industries: Healthcare & life sciences (8), Real estate (3), Financial services (1)
  • Largest disclosed fee: $27.5M, advising the acquirer on Supernus Pharmaceuticals, Inc. (2026) DEFM14ASep 2026

The 8 most recent of 13 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Cherry Hill Mortgage Investment Corpacquired by AG Mortgage Investment Trustacquirer$15.1M$1.25M—DEFM14AOct 2026
Supernus Pharmaceuticals, Inc.acquired by Indivioracquirer—$27.5M—DEFM14ASep 2026
Sotherly Hotels Inc.acquired by Kwhpspecial committee$46.1M$1M2.17%DEFM14ADec 2025
Potbelly Corporationacquired by RaceTractarget company$409M$6.9M1.69%SC 14D9Sep 2025
iCAD, Inc.acquired by RadNet, Inc.target company—$3M—DEFM14AMay 2025
Evans Bancorp, Inc.acquired by NBT Bancorptarget company—$3.9M—DEFM14ANov 2024
Miromatrix Medical Inc.acquired by United Therapeutics Corporationtarget company$89.1M$2.5M2.81%SC 14D9Nov 2023
Miromatrix Medical Inc.acquired by United Therapeutics Corporationtarget company$88.8M$2.5M2.82%SC 14D9Nov 2023

PJT Partners

PJT Partners disclosed 13 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (10 for the sell side, 3 for the acquirer), with a median fee of $26.2M; where deal value is known, the median was 0.80% of deal value across 8 deals, on a median deal of $6.51B.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $5M (11 disclosures)
  • Share of the fee payable only on closing: median 91.2% (5 disclosures)
  • Industries: Financial services (5), Consumer & retail (4), Industrials & business services (2)
  • Largest disclosed fee: $75M, advising the acquirer on The Interpublic Group of Companies, Inc. (2025) DEFM14AJan 2025

The 8 most recent of 13 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
First Eagle Investmentsacquired by Victory Capital Holdingsacquirer$7.03B$52.5M0.75%DEFM14AOct 2026
DoubleVerify Holdings, Inc.acquired by Elliottspecial committee$2.05B$23M1.12%DEFM14ASep 2026
Caesars Entertainment, Inc.acquired by Feitarget company$6.32B$35M0.55%DEFM14AAug 2026
Clearwater Analytics Holdings, Inc.special committee$7.89B$42.2M0.53%DEFM14AApr 2026
Kenvue Inc.acquired by Kimberly-Clarkacquirer$6.71B$57M0.85%DEFM14ADec 2025
Core Scientific, Inc.acquired by CoreWeavetarget company—$10M—DEFM14ASep 2025
Playa Hotels & Resorts N.V.acquired by Hyatt Hotels Corporationtarget's board—$26.2M—SC 14D9Apr 2025
Playa Hotels & Resorts N.V.acquired by Hyatt Hotels Corporationtarget's board$1.66B$26.2M1.58%DEFM14AMar 2025

Keefe, Bruyette & Woods

Keefe, Bruyette & Woods disclosed 9 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (6 for the sell side, 3 for the acquirer), with a median fee of $4.5M; where deal value is known, the median was 1.21% of deal value across 4 deals, on a median deal of $832M.

  • Tier: Not on a tier list
  • Median fairness-opinion fee: $500K (9 disclosures)
  • Share of the fee payable only on closing: median 86.6% (8 disclosures)
  • Industries: Financial services (6), Other (3)
  • Largest disclosed fee: $13.5M, advising the target company on First Bancshares Inc. /ms/ (2024) DEFM14ASep 2024

The 8 most recent of 9 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Bowhead Specialty Holdings Inc.acquired by American Familyacquirer$1.12B$7.13M0.64%DEFM14AOct 2026
Flushing Financial Corporationacquired by OceanFirstacquirer$543M$7M1.29%DEFM14AFeb 2026
Southern States Bancshares, Inc.acquired by FB Financial Corporationacquirer—$4.5M—DEFM14AMay 2025
Goldman Sachs Private Middle Market Credit LLCtarget company—$1M—DEFM14ANov 2024
CrossFirst Bankshares, Inc.acquired by Buseytarget company—$8.9M—DEFM14ANov 2024
Blue Owl Capital Corporation IIIacquired by Obdctarget company—$1.5M—DEFM14AOct 2024
First Bancshares Inc. /ms/acquired by Renasanttarget company$1.2B$13.5M1.13%DEFM14ASep 2024
Codorus Valley Bancorp Inc.acquired by Orrstown Financial Servicestarget company—$2.75M—DEFM14AApr 2024

Kroll

Kroll disclosed 9 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (7 for the sell side, 2 for the acquirer), with a median fee of $575K.

  • Tier: Middle market
  • Median fairness-opinion fee: $243K (6 disclosures)
  • Share of the fee payable only on closing: median 69.6% (3 disclosures)
  • Industries: Financial services (3), Industrials & business services (2), Consumer & retail (2)
  • Largest disclosed fee: $700K, advising the special committee on Fathom Digital Manufacturing Corp (2024) DEFM14AApr 2024

The 8 most recent of 9 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
Allbirds, Inc.acquired by American Exchange Groupspecial committee$39M$300K0.77%DEFM14AMay 2026
Bakkt, Inc.acquired by Dtrspecial committee—$650K—DEFM14AFeb 2026
Emeren Group Ltdspecial committee—$320K—DEFM14AOct 2025
Checkpoint Therapeutics, Inc.acquired by Sun Pharmaceutical Industries (LW Securities engaged)special committee$475M$400K0.08%DEFM14AApr 2025
Lionsgate Studios Corp.special committee—$650K—DEFM14AMar 2025
Blyvooracquired by Rigel Resource Acquisition Corpacquirer—$575K—DEFM14AJan 2025
Fathom Digital Manufacturing Corpacquired by CORE Industrial Partnersspecial committee—$700K—DEFM14AApr 2024
Fathom Digital Manufacturing Corpacquired by CORE Industrial Partnersspecial committee—$30K—DEFM14AApr 2024

Perella Weinberg Partners

Perella Weinberg Partners disclosed 9 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (9 for the sell side, 0 for the acquirer), with a median fee of $6M; where deal value is known, the median was 2.12% of deal value across 4 deals, on a median deal of $180M.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $2M (6 disclosures)
  • Share of the fee payable only on closing: median 86.8% (8 disclosures)
  • Industries: Industrials & business services (5), Healthcare & life sciences (3), Energy, mining & utilities (1)
  • Largest disclosed fee: $36M, advising the target company on LCI Industries (2026) DEFM14AOct 2026

The 8 most recent of 9 disclosed engagements; all of them are in every disclosed fee below.

TargetAdvisingDeal valueFee% of valueSource
LCI Industriesacquired by Patrick Industriestarget company—$36M—DEFM14AOct 2026
Akoya Biosciences, Inc.acquired by Quanterix Corporationtarget company—$3.5M—DEFM14AJun 2025
Akoya Biosciences, Inc.acquired by Quanterix Corporationtarget company$199M$3.5M1.76%DEFM14AApr 2025
Arch Resources, Inc.acquired by Consoltarget company—$31M—DEFM14ANov 2024
Alimera Sciences, Inc.target company$498M$7M1.41%DEFM14AAug 2024
Eargo, Inc.target company$52.9M$2M3.78%DEFM14AJan 2024
SomaLogic, Inc.acquired by Standard BioTools Inc.target company—$6M—DEFM14ADec 2023
Eneti Inc.acquired by Cadeler A/Starget company—$15M—SC 14D9Nov 2023

Truist Securities

Truist Securities disclosed 8 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (8 for the sell side, 0 for the acquirer), with a median fee of $7.7M; where deal value is known, the median was 1.75% of deal value across 5 deals, on a median deal of $715M.

  • Tier: Middle market
  • Median fairness-opinion fee: $1M (5 disclosures)
  • Share of the fee payable only on closing: median 84.8% (6 disclosures)
  • Industries: Real estate (2), Healthcare & life sciences (2), Industrials & business services (2)
  • Largest disclosed fee: $23.7M, advising the target company on Performant Healthcare, Inc. (2025) DEFM14ASep 2025

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
Sanara MedTech Inc.acquired by MiMedxtarget company$4.82B$6.1M0.13%DEFM14ASep 2026
Modiv Industrial, Inc.acquired by Gnltarget company—$2.25M—DEFM14AJun 2026
Marine Products Corporationacquired by MasterCrafttarget company$85.6M$5.5M6.42%DEFM14AApr 2026
DENNY'S Corptarget company$640M$9.3M1.45%DEFM14ADec 2025
Performant Healthcare, Inc.acquired by Continentaltarget company$715M$23.7M3.31%DEFM14ASep 2025
Goldman Sachs Middle Market Lending Corp. IIspecial committee—$2.5M—DEFM14AAug 2025
Atrion Corporationacquired by Nordsontarget company$815M$14.3M1.75%DEFM14AJul 2024
The Necessity Retail REIT, Inc.acquired by Global Net Lease, Inc.special committee—$11M—DEFM14AJul 2023

Newbridge

Newbridge disclosed 7 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (5 for the sell side, 2 for the acquirer), with a median fee of $75K.

  • Tier: Not on a tier list
  • Median fairness-opinion fee: $45K (7 disclosures)
  • Share of the fee payable only on closing: median 33.3% (4 disclosures)
  • Industries: Financial services (5), Industrials & business services (1), Consumer & retail (1)
  • Largest disclosed fee: $150K, advising the target's board on Alphatime Acquisition Corp (2025) DEFM14ANov 2025

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
Willow Lane Acquisition Corp.target company—$100K—DEFM14AApr 2026
Alphatime Acquisition Corptarget's board$75M$150K—DEFM14ANov 2025
Yerbae Brands Corp.acquired by Safety Shot, Inc.Other parties—$50K—DEFM14AMay 2025
Safety Shot, Inc.acquired by Yerbae Brands Corp.target's board—$50K—DEFM14AMay 2025
Aimfinity Investment Corp. Iacquired by Doctertarget's board$60M$75K—DEFM14AMar 2025
Zoozacquired by Keyarch Acquisition Corpacquirer$60M$90K—DEFM14AMar 2024
Filament Health Corp.acquired by Jupiter Acquisition Corporationacquirer$176M$75K—DEFM14ANov 2023

Raymond James

Raymond James disclosed 7 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (4 for the sell side, 3 for the acquirer), with a median fee of $2.25M; where deal value is known, the median was 1.26% of deal value across 3 deals, on a median deal of $124M.

  • Tier: Middle market
  • Median fairness-opinion fee: $350K (4 disclosures)
  • Share of the fee payable only on closing: median 94.4% (6 disclosures)
  • Industries: Financial services (3), Industrials & business services (2), Technology & telecom (2)
  • Largest disclosed fee: $12M, advising the target company on Paya Holdings Inc. (2023) SC 14D9Jan 2023

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
CrossFirst Bankshares, Inc.acquired by Buseyacquirer—$6.75M—DEFM14ANov 2024
HMN Financial, Inc.acquired by Alerusacquirer$124M$1.45M1.17%DEFM14AAug 2024
Codorus Valley Bancorp Inc.acquired by Orrstown Financial Servicesacquirer—$1.8M—DEFM14AApr 2024
PFSweb, Inc.target company$159M$2M1.26%SC 14D9Sep 2023
Computer Task Group, Incorporatedacquired by Cegekatarget company$96.3M$4.8M4.99%SC 14D9Aug 2023
Limeade, Inc.acquired by WebMDtarget company—$2.25M—DEFM14AJul 2023
Paya Holdings Inc.acquired by Nuveitarget company—$12M—SC 14D9Jan 2023

Allen & Company

Allen & Company disclosed 6 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (5 for the sell side, 1 for the acquirer), with a median fee of $37.5M.

  • Tier: Not on a tier list
  • Median fairness-opinion fee: $7.75M (4 disclosures)
  • Share of the fee payable only on closing: median 85.4% (6 disclosures)
  • Industries: Technology & telecom (5), Healthcare & life sciences (1)
  • Largest disclosed fee: $100M, advising the target company on Warner Bros. Discovery, Inc. (2026) DEFM14AMar 2026

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
Roku, Inc.acquired by Foxacquirer—$55M—DEFM14ASep 2026
Warner Bros. Discovery, Inc.acquired by Paramount Skydancetarget company$68.8B$100M0.15%DEFM14AMar 2026
Eventbrite, Inc.acquired by Bending Spoons S.p.A.target company—$20M—DEFM14AJan 2026
Warner Bros. Discovery, Inc.acquired by Netflixtarget company$74.3B$85M0.11%SC 14D9Dec 2025
Shutterstock, Inc.acquired by Getty Images Holdings, Inc.target company—$20M—DEFM14AApr 2025
Recursion Pharmaceuticals, Inc.target company—$14M—DEFM14AOct 2024

Moelis & Company

Moelis & Company disclosed 6 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (6 for the sell side, 0 for the acquirer), with a median fee of $19.5M; where deal value is known, the median was 2.06% of deal value across 3 deals, on a median deal of $1.52B.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $3M (3 disclosures)
  • Industries: Industrials & business services (4), Energy, mining & utilities (1), Real estate (1)
  • Largest disclosed fee: $45M, advising the special committee on Vista Outdoor Inc. (2024) DEFM14AOct 2024

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
Kennedy-Wilson Holdings, Inc.acquired by Fairfax Financial Holdings Limitedspecial committee$1.52B$33M2.17%DEFM14AMay 2026
Clear Channel Outdoor Holdings, Inc.acquired by Mubadala Capitaltarget company$1.21B$25M2.06%DEFM14AApr 2026
Spirit AeroSystems Holdings, Inc.acquired by Boeingtarget company—$5M—DEFM14ADec 2024
Vista Outdoor Inc.special committee$3.35B$45M—DEFM14AOct 2024
Avangrid, Inc.acquired by Iberdrolaspecial committee$13.3B$14M0.11%DEFM14AAug 2024
Vista Outdoor Inc.acquired by CSG (Czechoslovak Group)Other parties$1.91M$3.5M—DEFM14AApr 2024

BMO

BMO disclosed 5 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (4 for the sell side, 1 for the acquirer), with a median fee of $17.2M.

  • Tier: Not on a tier list
  • Median fairness-opinion fee: $3M (3 disclosures)
  • Share of the fee payable only on closing: median 76.2% (3 disclosures)
  • Industries: Real estate (2), Energy, mining & utilities (2), Consumer & retail (1)
  • Largest disclosed fee: $30M, advising the special committee on The Necessity Retail REIT, Inc. (2023) DEFM14AJul 2023

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
Centerspaceacquired by Independence Realty Trusttarget company—$17.2M—DEFM14AOct 2026
Coeur Mining, Inc.acquired by New Goldtarget company—$21M—DEFM14ADec 2025
SilverCrest Metalsacquired by Coeur Mining, Inc.acquirer—$10M—DEFM14ADec 2024
Primo Water Corporationacquired by BlueTritontarget company—$6.5M—DEFM14AOct 2024
The Necessity Retail REIT, Inc.acquired by Global Net Lease, Inc.special committee—$30M—DEFM14AJul 2023

Rothschild

Rothschild & Co disclosed 5 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (3 for the sell side, 2 for the acquirer), with a median fee of $14.3M.

  • Tier: Elite boutique
  • Median fairness-opinion fee: $2.75M (4 disclosures)
  • Share of the fee payable only on closing: median 80.0% (3 disclosures)
  • Industries: Technology & telecom (2), Industrials & business services (2), Real estate (1)
  • Largest disclosed fee: $46M, advising the special committee on Global Business Travel Group, Inc. (2026) DEFM14AJul 2026

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
Centerspaceacquired by Independence Realty Trustacquirer—$7.5M—DEFM14AOct 2026
Global Business Travel Group, Inc.special committee$4.95B$46M0.93%DEFM14AJul 2026
KORE Group Holdings, Inc.acquired by Searchlightspecial committee$700M$5M—DEFM14AJun 2026
American Woodmark Corporationacquired by MasterBrandacquirer—$15M—DEFM14ASep 2025
Consolidated Communications Holdings, Inc.acquired by Searchlight Capital Partners (SL Investor)special committee$547M$14.3M2.61%DEFM14ADec 2023

William Blair

William Blair disclosed 5 advisor fees in US merger proxies and tender-offer statements filed 2023–2026 (5 for the sell side, 0 for the acquirer), with a median fee of $1M; where deal value is known, the median was 0.62% of deal value across 3 deals, on a median deal of $162M.

  • Tier: Middle market
  • Median fairness-opinion fee: $1M (5 disclosures)
  • Industries: Healthcare & life sciences (3), Industrials & business services (2)
  • Largest disclosed fee: $3.5M, advising the target company on Science 37 Holdings, Inc. (2024) SC 14D9Feb 2024

Every disclosed engagement:

TargetAdvisingDeal valueFee% of valueSource
ARC Document Solutions, Inc.special committee$162M$1M0.62%DEFM14AOct 2024
Science 37 Holdings, Inc.target company—$3.5M—SC 14D9Mar 2024
Science 37 Holdings, Inc.target company$746M$3.5M0.47%SC 14D9Feb 2024
Acer Therapeutics Inc.acquired by Zevra Therapeutics, Inc.target company—$1M—DEFM14AOct 2023
PhenomeX Inc.acquired by Bruker Corporationtarget company$99.3M$1M1.01%SC 14D9Aug 2023

A named firm’s figures are what it was paid on the specific engagements disclosed in these filings. They are not the firm’s rate card, the firm may charge differently on other work, and inclusion here does not imply any endorsement by or affiliation with the firm.

Every disclosed fee

Hover over a fee to see the sentence it comes from. The line under each advisor shows which side of the deal it advised.

797 rows
TargetAdvisorDeal valueTotal feeOpinion feeSource
Distribution Solutions GroupWilliam Blairadvising the target——$2MDEFM14AOct 2026
Mistras GroupRobert W. Bairdadvising the target—$13M—DEFM14AOct 2026
Blockfusionacquired by Blue Acquisition CorpINGadvising the target$450Mstated$2.25M—DEFM14AOct 2026
Personalisacquired by Tempus AICenterview Partnersadvising the target—$29.4M$1MDEFM14AOct 2026
Personalisacquired by Tempus AITD Cowenadvising the target—$15M—DEFM14AOct 2026
Personalisacquired by Tempus AIMorgan Stanleyadvising the acquirer—$15M$3MDEFM14AOct 2026
SoundThinkingTidaladvising the target—$4.7M$2MSC 14D9Oct 2026
Greenbacker Renewable EnergyWells Fargo Securitiesadvising the target$375Mstated$7M$1.75MDEFM14AOct 2026
LCI Industriesacquired by Patrick IndustriesJ.P. Morganadvising the acquirer—$20M$5MDEFM14AOct 2026
LCI Industriesacquired by Patrick IndustriesRobert W. Bairdadvising the acquirer—$12.5M—DEFM14AOct 2026
LCI Industriesacquired by Patrick IndustriesPerella Weinberg Partnersadvising the target—$36M$5MDEFM14AOct 2026
First Eagle Investmentsacquired by Victory Capital HoldingsPJT Partnersadvising the acquirer$7.03Bstated$52.5M$5MDEFM14AOct 2026
Bowhead Specialty Holdings Inc.acquired by American FamilyArdeaadvising the target$1.12Bcomputed$9.5M—DEFM14AOct 2026
Bowhead Specialty Holdings Inc.acquired by American FamilyKeefe, Bruyette & Woodsadvising the acquirer$1.12Bcomputed$7.13M$1.5MDEFM14AOct 2026
Cherry Hill Mortgage Investment Corpacquired by AG Mortgage Investment TrustBTIGadvising the target$15.1Mcomputed$2.5M$500KDEFM14AOct 2026
Cherry Hill Mortgage Investment Corpacquired by AG Mortgage Investment TrustPiper Sandleradvising the acquirer$15.1Mcomputed$1.25M—DEFM14AOct 2026
Centerspaceacquired by Independence Realty TrustBMOadvising the target—$17.2M$2.5MDEFM14AOct 2026
Centerspaceacquired by Independence Realty TrustRBC Capital Marketsadvising the acquirer—$12M$1.5MDEFM14AOct 2026
Centerspaceacquired by Independence Realty TrustRothschildadvising the acquirer—$7.5M—DEFM14AOct 2026
Everliacquired by Melar Acquisition Corp. ICohenadvising the acquirer$180Mstated$1.5M—DEFM14AOct 2026
Novagold Resources Inc.Citiadvising the target—$11.5M$1.25MDEFM14AOct 2026
Bowman Consulting Group Ltd.acquired by BernhardBofA Securitiesadvising the target$573Mcomputed$14.8M$2MDEFM14AOct 2026
DoubleVerify Holdings, Inc.acquired by ElliottPJT Partnersadvising the special_committee$2.05Bcomputed$23M$2MDEFM14ASep 2026
Weave Communications, Inc.acquired by Francisco PartnersJefferiesadvising the target$762Mcomputed$15.9M$2MDEFM14ASep 2026
Nathans Famous, Inc.Jefferiesadvising the target$418Mcomputed$9.6M$1MDEFM14ASep 2026
Varex Imaging Corpacquired by TeledyneEvercoreadvising the target$695Mcomputed$36.4M$2MDEFM14ASep 2026
CBIZ, Inc.acquired by Grant ThorntonGoldman Sachsadvising the target$2.98Bcomputed$53M—DEFM14ASep 2026
LXP Industrial TrustBofA Securitiesadvising the target$3.61Bcomputed$13M$2.5MDEFM14ASep 2026
Sunrise Realty Trust, Inc.Oppenheimeradvising the target$676Kcomputed$750K$500KDEFM14ASep 2026
Marketaxess Holdings Inc.J.P. Morganadvising the target$5.88Bcomputed$65.5M$3MDEFM14ASep 2026
Luxfer Holdings PLCDeutsche Bankadvising the target$465Mcomputed$8M$1MDEFM14ASep 2026
ACV Auctions Inc.acquired by CopartJ.P. Morganadvising the target$1.78Bcomputed$26M$4MSC 14D9Sep 2026
Trico Bancshares /acquired by First HawaiianEvercoreadvising the acquirer—$19M$3MDEFM14ASep 2026
Trico Bancshares /acquired by First HawaiianKeefe, Bruyette & Woodsadvising the target——$2MDEFM14ASep 2026
Gran Tierra Energy Inc.acquired by Maurel & PromBofA Securitiesadvising the target—$10M$2MDEFM14ASep 2026
Safety Insurance Group Inc.acquired by MapfreJefferiesadvising the target$1.51Bcomputed$17.5M$2.5MDEFM14ASep 2026
Integer Holdings Corpacquired by KkrGoldman Sachsadvising the target$4.32Bcomputed$85.7M—DEFM14ASep 2026
Supernus Pharmaceuticals, Inc.acquired by IndiviorJefferiesadvising the acquirer—$27.5M—DEFM14ASep 2026
Supernus Pharmaceuticals, Inc.acquired by IndiviorPiper Sandleradvising the acquirer—$27.5M$1.5MDEFM14ASep 2026
Supernus Pharmaceuticals, Inc.acquired by IndiviorCantor Fitzgeraldadvising the target—$30M$2MDEFM14ASep 2026
Atkore Inc.acquired by PrysmianCitiadvising the target$2.6Bcomputed$38M$2.5MDEFM14ASep 2026
Atkore Inc.acquired by PrysmianJ.P. Morganadvising the target$2.6Bcomputed$21.5M$3MDEFM14ASep 2026
Lantheus Holdings, Inc.acquired by CapVestMorgan Stanleyadvising the target$6.69Bcomputed$81M$10.5MDEFM14ASep 2026
Sanara MedTech Inc.acquired by MiMedxTruist Securitiesadvising the target$4.82Bcomputed$6.1M—DEFM14ASep 2026
Biolife Solutions Inc.acquired by RepligenCenterview Partnersadvising the target$1.58Bstated$25M$1MDEFM14ASep 2026
Roku, Inc.acquired by FoxAllen & Companyadvising the acquirer—$55M$5.5MDEFM14ASep 2026
Caesars Entertainment, Inc.acquired by FeiPJT Partnersadvising the target$6.32Bcomputed$35M$5MDEFM14AAug 2026
LogicMark, Inc.Roth Capital Partnersadvising the target$1.18Mcomputed$210K—DEFM14AAug 2026
Theravance Biopharma, Inc.Lazardadvising the target$883Mcomputed$23M$2MDEFM14AAug 2026
BIO-TECHNE CorpGoldman Sachsadvising the target$11.3Bstated$106M—DEFM14AAug 2026
First Real Estate Investment Trust Of New Jersey, Inc.JLLadvising the target—$400K$400KDEFM14AAug 2026
AstroNova, Inc.acquired by ArclineRockefelleradvising the target$225Mcomputed$4.2M$1MDEFM14AJul 2026
Crinetics Pharmaceuticals, Inc.J.P. Morganadvising the target$9.02Bcomputed$69.4M$2MDEFM14AJul 2026
Crinetics Pharmaceuticals, Inc.Leerink Partnersadvising the target$9.02Bcomputed$60.8M$2MDEFM14AJul 2026
Dominion Energy, Inc.acquired by NextEra EnergyGoldman Sachsadvising the target—$47M$5MDEFM14AJul 2026
Dominion Energy, Inc.acquired by NextEra EnergyLazardadvising the acquirer—$70M$5MDEFM14AJul 2026
Dominion Energy, Inc.acquired by NextEra EnergyBofA Securitiesadvising the acquirer—$30M$5MDEFM14AJul 2026
Dominion Energy, Inc.acquired by NextEra EnergyJ.P. Morganadvising the target—$78M—DEFM14AJul 2026
Simulations Plus, Inc.Morgan Stanleyadvising the target$375Mstated$11M$2MDEFM14AJul 2026
Avalonbay Communities Inc.acquired by Equity ResidentialMorgan Stanleyadvising the acquirer$24.7Bstated$50M$5MDEFM14AJul 2026
Avalonbay Communities Inc.acquired by Equity ResidentialGoldman Sachsadvising the target$24.7Bstated$65M$3MDEFM14AJul 2026
Huntsman CORPacquired by OlinLazardadvising the acquirer—$24M$5MDEFM14AJul 2026
Huntsman CORPacquired by OlinCitiadvising the target—$21M$2MDEFM14AJul 2026
Huntsman CORPacquired by OlinMorgan Stanleyadvising the target—$9M$2MDEFM14AJul 2026
Apogee Therapeutics, Inc.acquired by AbbVieGoldman Sachsadvising the target$10Bstated$65M—DEFM14AJul 2026
Apogee Therapeutics, Inc.acquired by AbbVieJefferiesadvising the target$10Bstated$65M$2MDEFM14AJul 2026
Liveperson Inc.acquired by SoundHoundHoulihan Lokeyadvising the target—$1.5M—DEFM14AJul 2026
Global Business Travel Group, Inc.Rothschildadvising the special_committee$4.95Bcomputed$46M$4MDEFM14AJul 2026
Texas Mineral Resources Corp.acquired by UsarRoth Capital Partnersadvising the target——$350KDEFM14AJun 2026
Open Lending Corpacquired by AnvFTadvising the target$236Mcomputed$8.7M$1MSC 14D9Jun 2026
Nuvalent, Inc.Centerview Partnersadvising the target$10.6Bstated$100M$2MSC 14D9Jun 2026
Modiv Industrial, Inc.acquired by GnlTruist Securitiesadvising the target—$2.25M$750KDEFM14AJun 2026
Corebridge Financial, Inc.acquired by Equitable Holdings, Inc.Morgan Stanleyadvising the target—$60M$5MDEFM14AJun 2026
Corebridge Financial, Inc.acquired by Equitable Holdings, Inc.Goldman Sachsadvising the acquirer—$50M—DEFM14AJun 2026
Equitable Holdings, Inc.acquired by Corebridge Financial, Inc.Goldman Sachsadvising the target—$50M—DEFM14AJun 2026
Equitable Holdings, Inc.acquired by Corebridge Financial, Inc.Morgan Stanleyadvising the acquirer—$60M$5MDEFM14AJun 2026
Organon & Co.acquired by Sun PharmaMorgan Stanleyadvising the target$3.68Bcomputed$39.4M$4MDEFM14AJun 2026
Cross Country Healthcare Inc.BofA Securitiesadvising the target$428Mcomputed$6.12M$2MDEFM14AJun 2026
National Storage Affiliates Trustacquired by Public StorageMorgan Stanleyadvising the target—$58.8M$5MDEFM14AJun 2026
KORE Group Holdings, Inc.acquired by SearchlightRothschildadvising the special_committee$700Mstated$5M$1.5MDEFM14AJun 2026
KORE Group Holdings, Inc.acquired by SearchlightTD Cowenadvising the acquirer$700Mstated$6M—DEFM14AJun 2026
XOMA Royalty CorpLeerink Partnersadvising the target$489Mcomputed$18.4M$1MDEFM14AJun 2026
Avanos Medical, Inc.acquired by AipJ.P. Morganadvising the target$4.13Mcomputed$20M—DEFM14AJun 2026
Catalyst Pharmaceuticals, Inc.J.P. Morganadvising the target$3.86Bcomputed$61M$3.5MDEFM14AJun 2026
Esperion Therapeutics, Inc.Centerview Partnersadvising the target$703Mcomputed$37.5M$1.5MDEFM14AJun 2026
TruBridge, Inc.acquired by IksSolomonadvising the target$450Mcomputed—$2.5MDEFM14AJun 2026
TopBuild Corpacquired by QxoGoldman Sachsadvising the target$6.4Bcomputed$70M—DEFM14AMay 2026
TopBuild Corpacquired by QxoRBCCMadvising the target$6.4Bcomputed$60M—DEFM14AMay 2026
NCR Atleos Corpacquired by Brink'sJ.P. Morganadvising the target$2.21Bcomputed$43M$4MDEFM14AMay 2026
Sila Realty Trust, Inc.acquired by Blue OwlBofA Securitiesadvising the target$1.57Bcomputed$24.9M$2.5MDEFM14AMay 2026
Select Medical Holdings Corpacquired by WcasGoldman Sachsadvising the special_committee$2.05Bcomputed$11M—DEFM14AMay 2026
Select Medical Holdings Corpacquired by WcasWells Fargo Securitiesadvising the acquirer$2.05Bcomputed$11.5M—DEFM14AMay 2026
Select Medical Holdings Corpacquired by WcasJ.P. Morganadvising the acquirer$2.05Bcomputed$10M—DEFM14AMay 2026
Whitestone REITJLLadvising the target$781Mcomputed$6.25M—DEFM14AMay 2026
Whitestone REITBofA Securitiesadvising the target$781Mcomputed$17.5M$2MDEFM14AMay 2026
Aes CorpJ.P. Morganadvising the target$502Mcomputed$75M$4MDEFM14AMay 2026
Aes CorpWells Fargo Securitiesadvising the target$502Mcomputed$15M$4MDEFM14AMay 2026
M3-Brigade Acquisition V Corp.acquired by ReserveOneLincolnadvising the special_committee—$550K—DEFM14AMay 2026
KalVista Pharmaceuticals, Inc.Centerview Partnersadvising the target$1.08Bcomputed$44M$2MSC 14D9May 2026
KalVista Pharmaceuticals, Inc.Jefferiesadvising the target$1.08Bcomputed$29.7M$1.5MSC 14D9May 2026
Unifirst Corpacquired by CintasJ.P. Morganadvising the target$5.46Bcomputed$42M$5MDEFM14AMay 2026
Unifirst Corpacquired by CintasGoldman Sachsadvising the target$5.46Bcomputed$42M$5MDEFM14AMay 2026
Green Dot CorpCitiadvising the target—$13M$3MDEFM14AMay 2026
Allbirds, Inc.acquired by American Exchange GroupTD Cowenadvising the target$39Mstated$2M—DEFM14AMay 2026
Allbirds, Inc.acquired by American Exchange GroupKrolladvising the special_committee$39Mstated$300K—DEFM14AMay 2026
Centessa Pharmaceuticals plcacquired by LillyCenterview Partnersadvising the target—$66M$1.25MDEFM14AMay 2026
Centessa Pharmaceuticals plcacquired by LillyJefferiesadvising the target—$27.6M$1.25MDEFM14AMay 2026
Kennedy-Wilson Holdings, Inc.acquired by Fairfax Financial Holdings LimitedMoelis & Companyadvising the special_committee$1.52Bcomputed$33M$2.5MDEFM14AMay 2026
Thermon Group Holdings, Inc.acquired by CecoCitiadvising the acquirer$2.1Bcomputed$17.5M$3MDEFM14AApr 2026
Thermon Group Holdings, Inc.acquired by CecoMorgan Stanleyadvising the target$2.1Bcomputed$42.5M—DEFM14AApr 2026
Webster Financial Corpacquired by SantanderJ.P. Morganadvising the target$7.86Bcomputed$75M$7.5MDEFM14AApr 2026
Soleno Therapeutics Inc.Centerview Partnersadvising the target$4.44Bcomputed$40M$2MSC 14D9Apr 2026
Soleno Therapeutics Inc.Guggenheim Securitiesadvising the target$4.44Bcomputed$33M—SC 14D9Apr 2026
Talkspace, Inc.acquired by UhsWells Fargo Securitiesadvising the target$710Mcomputed$15.7M$3MDEFM14AApr 2026
Urgent.ly Inc.Pericles Capitaladvising the target$12.1Mcomputed$4.31M—SC 14D9Apr 2026
Sphere 3D Corp.acquired by CathedraRosenblattadvising the target——$175KDEFM14AApr 2026
Forian Inc.Houlihan Lokeyadvising the special_committee$65.5Mcomputed$2.5M$1.25MSC 14D9Apr 2026
Fonar CorpMarshall & Stevensadvising the special_committee$66.8Mcomputed$120K$120KDEFM14AApr 2026
Kezar Life Sciences, Inc.TD Cowenadvising the target$51.3Mcomputed$2.5M$1MSC 14D9Apr 2026
Enhabit, Inc.acquired by KinderhookGoldman Sachsadvising the target$707Mcomputed$24.8M—DEFM14AApr 2026
Apellis Pharmaceuticals, Inc.acquired by BiogenEvercoreadvising the target$3.96Bcomputed$76M$2MSC 14D9Apr 2026
Clear Channel Outdoor Holdings, Inc.acquired by Mubadala CapitalMorgan Stanleyadvising the target$1.21Bcomputed—$5MDEFM14AApr 2026
Clear Channel Outdoor Holdings, Inc.acquired by Mubadala CapitalMoelis & Companyadvising the target$1.21Bcomputed$25M—DEFM14AApr 2026
Veris Residential, Inc.J.P. Morganadvising the target$1.78Bcomputed$22M$3MDEFM14AApr 2026
Veris Residential, Inc.Morgan Stanleyadvising the target$1.78Bcomputed$17M$1.5MDEFM14AApr 2026
Willow Lane Acquisition Corp.Newbridgeadvising the target—$100K$80KDEFM14AApr 2026
Clearwater Analytics Holdings, Inc.PJT Partnersadvising the special_committee$7.89Bstated$42.2M$5MDEFM14AApr 2026
Clearwater Analytics Holdings, Inc.J.P. Morganadvising the target$7.89Bstated$51M$5MDEFM14AApr 2026
Terns Pharmaceuticals, Inc.acquired by MerckCenterview Partnersadvising the target$6.69Bcomputed$50.5M$2MSC 14D9Apr 2026
Terns Pharmaceuticals, Inc.acquired by MerckJefferiesadvising the target$6.69Bcomputed$37M$2MSC 14D9Apr 2026
ENVIRI Corpacquired by VeoliaBofA Securitiesadvising the target$3.04Bstated$46M—DEFM14AApr 2026
European Wax Center, Inc.acquired by General AtlanticMoelis & Companyadvising the target——$2MDEFM14AApr 2026
Marine Products Corporationacquired by MasterCraftWells Fargo Securitiesadvising the acquirer$85.6Mcomputed$4.25M$2MDEFM14AApr 2026
Marine Products Corporationacquired by MasterCraftTruist Securitiesadvising the target$85.6Mcomputed$5.5M—DEFM14AApr 2026
Masimo Corporationacquired by DanaherCenterview Partnersadvising the target$9.39Bcomputed$60M$5MDEFM14AApr 2026
Sun Country Airlines Holdings, Inc.acquired by AllegiantGoldman Sachsadvising the target$218Mcomputed$22.6M$2MDEFM14AMar 2026
Sun Country Airlines Holdings, Inc.acquired by AllegiantBarclaysadvising the acquirer$218Mcomputed—$3MDEFM14AMar 2026
SkyWater Technology, Inc.acquired by IonQGoldman Sachsadvising the target—$33M—DEFM14AMar 2026
Urgent.ly Inc.Periclesadvising the target$12.1Mcomputed$4.31M—SC 14D9Mar 2026
Coterra Energy Inc.acquired by Devon EnergyGoldman Sachsadvising the target—$37.5M—DEFM14AMar 2026
Devon Energy Corporationacquired by Coterra EnergyGoldman Sachsadvising the other—$37.5M—DEFM14AMar 2026
Farmer Bros. Co.acquired by BraemontNorth Pointadvising the target$41.5Mcomputed$1.5M$250KDEFM14AMar 2026
Warner Bros. Discovery, Inc.acquired by Paramount SkydanceAllen & Companyadvising the target$68.8Bcomputed$100M$20MDEFM14AMar 2026
Warner Bros. Discovery, Inc.acquired by Paramount SkydanceJ.P. Morganadvising the target$68.8Bcomputed$90M$20MDEFM14AMar 2026
Day One Biopharmaceuticals, Inc.acquired by ServierCenterview Partnersadvising the target$1.34Bcomputed$60M$2MSC 14D9Mar 2026
DigitalBridge Group, Inc.acquired by SoftBank GroupBarclaysadvising the target$2.19Bcomputed—$3MDEFM14AMar 2026
DigitalBridge Group, Inc.acquired by SoftBank GroupJ.P. Morganadvising the target$2.19Bcomputed$28M$3MDEFM14AMar 2026
Apollo Commercial Real Estate Finance, Inc.BofA Securitiesadvising the target$1.68Bstated$8M$3MDEFM14AMar 2026
Calavo Growers, Inc.acquired by Mission ProduceEvercoreadvising the acquirer$486Mstated$6.5M$1.5MDEFM14AMar 2026
Calavo Growers, Inc.acquired by Mission ProduceJefferiesadvising the target$486Mstated$12.5M$2MDEFM14AMar 2026
SunOpta Inc.Lazardadvising the target$769Mcomputed$17M$1MDEFM14AMar 2026
Peakstone Realty TrustBofA Securitiesadvising the target$632Mcomputed$16M$2MDEFM14AMar 2026
Janus Henderson Group plcGoldman Sachsadvising the special_committee$7.55Bcomputed$55M—DEFM14AMar 2026
Udemy, Inc.acquired by CourseraMorgan Stanleyadvising the target—$20M$1MDEFM14AMar 2026
Arcellx, Inc.Centerview Partnersadvising the target$5.73Bcomputed$100M$2MSC 14D9Mar 2026
Golden Entertainment, Inc.acquired by VICI PropertiesMacquarieadvising the other$72Mcomputed$9M$1.25MDEFM14AMar 2026
Golden Entertainment, Inc.acquired by VICI PropertiesSantanderadvising the other$72Mcomputed$8M—DEFM14AMar 2026
Flushing Financial Corporationacquired by OceanFirstKeefe, Bruyette & Woodsadvising the acquirer$543Mstated$7M$1MDEFM14AFeb 2026
Flushing Financial Corporationacquired by OceanFirstPSCadvising the target$543Mstated—$750KDEFM14AFeb 2026
RAPT Therapeutics, Inc.J.P. Morganadvising the target$1.39Bcomputed$50.4M$2MSC 14D9Feb 2026
Contango ORE, Inc.Canaccord Genuityadvising the target—$4.15M$400KDEFM14AFeb 2026
Bakkt, Inc.acquired by DtrKrolladvising the special_committee—$650K$350KDEFM14AFeb 2026
Heritage Commerce Corpacquired by CVB Financial CorpJ.P. Morganadvising the acquirer$811Mstated$9M$1MDEFM14AFeb 2026
Heritage Commerce Corpacquired by CVB Financial CorpPiper Sandleradvising the target$811Mstated—$1MDEFM14AFeb 2026
Ventyx Biosciences, Inc.acquired by Eli LillyJefferiesadvising the target$1Bcomputed$25.7M$2MDEFM14AFeb 2026
Ventyx Biosciences, Inc.acquired by Eli LillyMoelis & Companyadvising the target$1Bcomputed—$2MDEFM14AFeb 2026
RAPT Therapeutics, Inc.J.P. Morganadvising the target$1.39Bcomputed$50.4M$2MSC 14D9Feb 2026
Amicus Therapeutics, Inc.acquired by BioMarinGoldman Sachsadvising the target$4.47Bcomputed$52.7M—DEFM14AFeb 2026
Amicus Therapeutics, Inc.acquired by BioMarinCenterview Partnersadvising the target$4.47Bcomputed$52.7M$2MDEFM14AFeb 2026
The Brand House Collective, Inc.acquired by BbbyConsensusadvising the target——$150KDEFM14AJan 2026
Generation Bio Co.TD Cowenadvising the target—$1.6M$1MSC 14D9Jan 2026
Avidity Biosciences, Inc.acquired by NovartisGoldman Sachsadvising the target$7.84Bcomputed$108M$10MDEFM14AJan 2026
Avidity Biosciences, Inc.acquired by NovartisBarclaysadvising the target$7.84Bcomputed—$3.5MDEFM14AJan 2026
Diamond Hill Investment Group, Inc.acquired by First EagleBroadhavenadvising the target$430Mcomputed$7M$1MDEFM14AJan 2026
Eventbrite, Inc.acquired by Bending Spoons S.p.A.Allen & Companyadvising the target—$20M—DEFM14AJan 2026
Alexander & Baldwin, Inc.BofA Securitiesadvising the target$1.54Bcomputed$18.1M$2.5MDEFM14AJan 2026
Trailblazer Merger Corporation Iacquired by CyabraRoth Capital Partnersadvising the other$106Mstated$175K$175KDEFM14AJan 2026
Monroe Capital CorporationHoulihan Lokeyadvising the special_committee—$1.75M$500KDEFM14AJan 2026
First Foundation Inc.acquired by FirstSunStephensadvising the acquirer$784Mstated$8.25M—DEFM14AJan 2026
First Foundation Inc.acquired by FirstSunKeefe, Bruyette & Woodsadvising the target$784Mstated—$2MDEFM14AJan 2026
First Foundation Inc.acquired by FirstSunJefferiesadvising the target$784Mstated$2M$2MDEFM14AJan 2026
Olympic Steel, Inc.acquired by RyersonJ.P. Morganadvising the acquirer—$8M$3MDEFM14AJan 2026
Olympic Steel, Inc.acquired by RyersonKeyBancadvising the target—$7.5M$1MDEFM14AJan 2026
Dynavax Technologies CorporationCenterview Partnersadvising the target$1.82Bcomputed$30M$1MSC 14D9Jan 2026
Dynavax Technologies CorporationGoldman Sachsadvising the target$1.82Bcomputed$30M$1MSC 14D9Jan 2026
Generation Bio Co.TD Cowenadvising the target—$1.6M$1MSC 14D9Jan 2026
Confluent, Inc.acquired by IbmMorgan Stanleyadvising the target$9.53Bcomputed$84M$5MDEFM14AJan 2026
Exact Sciences Corporationacquired by AbbottCenterview Partnersadvising the target$19.9Bcomputed$70M$5MDEFM14AJan 2026
Exact Sciences Corporationacquired by AbbottXMSadvising the target$19.9Bcomputed$40M—DEFM14AJan 2026
Brighthouse Financial, Inc.acquired by AquarianGoldman Sachsadvising the target$4Bcomputed$41M—DEFM14AJan 2026
Brighthouse Financial, Inc.acquired by AquarianWells Fargo Securitiesadvising the target$4Bcomputed$41M$5MDEFM14AJan 2026
CNL Healthcare Properties, Inc.acquired by Sonida Senior Living, Inc.RBC Capital Marketsadvising the acquirer$1.8Bstated$10M$1.5MDEFM14AJan 2026
Synchronoss Technologies, Inc.acquired by Lumine GroupTD Cowenadvising the target$104Mcomputed$4.7M—DEFM14AJan 2026
Crawford United Corporationacquired by SpxLake Streetadvising the target$300Mstated$2.23M—DEFM14AJan 2026
Crawford United Corporationacquired by SpxStoutadvising the target$300Mstated$175K$175KDEFM14AJan 2026
Veeco Instruments Inc.acquired by Axcelis TechnologiesJ.P. Morganadvising the acquirer$612Mcomputed$27.5M$4MDEFM14ADec 2025
Veeco Instruments Inc.acquired by Axcelis TechnologiesUBSadvising the target$612Mcomputed$28.5M$3MDEFM14ADec 2025
Essential Utilities, Inc.acquired by American WaterBofA Securitiesadvising the acquirer—$45M$2.5MDEFM14ADec 2025
Semrush Holdings, Inc.acquired by AdobeCenterview Partnersadvising the target$1.51Bcomputed$33M$5MDEFM14ADec 2025
TreeHouse Foods, Inc.Goldman Sachsadvising the target$1.2Bstated$29.1M$1.5MDEFM14ADec 2025
Qorvo, Inc.acquired by Skyworks SolutionsGoldman Sachsadvising the acquirer—$8M—DEFM14ADec 2025
Qorvo, Inc.acquired by Skyworks SolutionsCenterview Partnersadvising the target—$74M$6MDEFM14ADec 2025
Hologic, Inc.Goldman Sachsadvising the target$334Mcomputed$109M—DEFM14ADec 2025
REV Group, Inc.acquired by TerexBarclaysadvising the acquirer——$4MDEFM14ADec 2025
REV Group, Inc.acquired by TerexJ.P. Morganadvising the target—$34M$3MDEFM14ADec 2025
PotlatchDeltic Corporationacquired by RayonierMorgan Stanleyadvising the acquirer—$20M$3MDEFM14ADec 2025
PotlatchDeltic Corporationacquired by RayonierBofA Securitiesadvising the target—$36M$1.5MDEFM14ADec 2025
Civitas Resources, Inc.acquired by SM EnergyEvercoreadvising the acquirer—$20M$2MDEFM14ADec 2025
Civitas Resources, Inc.acquired by SM EnergyJ.P. Morganadvising the target—$28M$3.5MDEFM14ADec 2025
Coeur Mining, Inc.acquired by New GoldBMOadvising the target—$21M—DEFM14ADec 2025
Coeur Mining, Inc.acquired by New GoldRBCCMadvising the target——$4.5MDEFM14ADec 2025
Plymouth Industrial REIT, Inc.acquired by Ares ManagementJ.P. Morganadvising the target$980Mcomputed$8M$1MDEFM14ADec 2025
Warner Bros. Discovery, Inc.acquired by NetflixAllen & Companyadvising the target$74.3Bcomputed$85M$10MSC 14D9Dec 2025
Warner Bros. Discovery, Inc.acquired by NetflixJ.P. Morganadvising the target$74.3Bcomputed$85M$5MSC 14D9Dec 2025
Warner Bros. Discovery, Inc.acquired by NetflixEvercoreadvising the target$74.3Bcomputed$55M—SC 14D9Dec 2025
Kenvue Inc.acquired by Kimberly-ClarkJ.P. Morganadvising the acquirer$6.71Bcomputed$50M$5MDEFM14ADec 2025
Kenvue Inc.acquired by Kimberly-ClarkPJT Partnersadvising the acquirer$6.71Bcomputed$57M$5MDEFM14ADec 2025
Kenvue Inc.acquired by Kimberly-ClarkCenterview Partnersadvising the target$6.71Bcomputed$63M$5MDEFM14ADec 2025
Kenvue Inc.acquired by Kimberly-ClarkGoldman Sachsadvising the target$6.71Bcomputed$63M—DEFM14ADec 2025
CSG Systems International, Inc.Jefferiesadvising the target$2.11Bcomputed$37M$1.5MDEFM14ADec 2025
Repare Therapeutics Inc.Leerink Partnersadvising the target—$4M$1MDEFM14ADec 2025
Forge Global Holdings, Inc.acquired by Charles SchwabFTadvising the target$550Mcomputed$11.3M$1.25MDEFM14ADec 2025
Sotherly Hotels Inc.acquired by KwhpPiper Sandleradvising the special_committee$46.1Mcomputed$1M—DEFM14ADec 2025
Jamf Holding Corp.acquired by Francisco PartnersCitiadvising the target$1.74Bcomputed$32M$4MDEFM14ADec 2025
Mersana Therapeutics, Inc.TD Cowenadvising the target—$3.5M—SC 14D9Dec 2025
Sonim Technologies Inc.Roth Capital Partnersadvising the special_committee$15Mstated$250K—DEFM14ADec 2025
Semler Scientific, Inc.acquired by StriveLionTreeadvising the target—$18M—DEFM14ADec 2025
Cidara Therapeutics, Inc.acquired by MerckEvercoreadvising the target$6.96Bcomputed$94M$1.5MSC 14D9Dec 2025
Cidara Therapeutics, Inc.acquired by MerckGoldman Sachsadvising the target$6.96Bcomputed$94M$1.5MSC 14D9Dec 2025
Avadel Pharmaceuticals PLCacquired by AlkermesMorgan Stanleyadvising the target$1.22Bcomputed$27M$2MDEFM14ADec 2025
Avadel Pharmaceuticals PLCacquired by AlkermesGoldman Sachsadvising the target$1.22Bcomputed$27M—DEFM14ADec 2025
Anywhere Real Estate Inc.acquired by CompassMorgan Stanleyadvising the acquirer—$24M$2.5MDEFM14ADec 2025
Anywhere Real Estate Inc.acquired by CompassGoldman Sachsadvising the target—$42M$3MDEFM14ADec 2025
DENNY'S CorpTruist Securitiesadvising the target$640Mstated$9.3M$2MDEFM14ADec 2025
Comerica Inc.acquired by Fifth ThirdGoldman Sachsadvising the acquirer—$50M—DEFM14ANov 2025
Comerica Inc.acquired by Fifth ThirdJ.P. Morganadvising the target—$75M$7.5MDEFM14ANov 2025
TrueCar, Inc.Morgan Stanleyadvising the target$227Mcomputed$12.5M—DEFM14ANov 2025
Electronic Arts Inc.Goldman Sachsadvising the target$52.4Bcomputed$110M—DEFM14ANov 2025
Evoke Pharma IncStifeladvising the target_board$18.9Mcomputed$2M$650KSC 14D9Nov 2025
Alphatime Acquisition CorpNewbridgeadvising the target_board$75Mstated$150K$50KDEFM14ANov 2025
Merus N.V.acquired by GenmabJefferiesadvising the target$6.14Bcomputed$90M$2MDEFM14ANov 2025
Vital Energy, Inc.acquired by CrescentIntrepidadvising the special_committee——$1MDEFM14ANov 2025
Vital Energy, Inc.acquired by CrescentHoulihan Lokeyadvising the target—$15M$3MDEFM14ANov 2025
Paramount Group, Inc.BofA Securitiesadvising the target$1.44Bcomputed$34.8M$3MDEFM14ANov 2025
Akero Therapeutics, Inc.acquired by NovoMorgan Stanleyadvising the target$4.45Bcomputed$53M$8MDEFM14ANov 2025
Akero Therapeutics, Inc.acquired by NovoJ.P. Morganadvising the target$4.45Bcomputed$35M$8MDEFM14ANov 2025
Steelcase Inc.acquired by HniGoldman Sachsadvising the target$879Mstated$33M—DEFM14ANov 2025
Steelcase Inc.acquired by HniJ.P. Morganadvising the acquirer$879Mstated$17.3M$3MDEFM14ANov 2025
Steelcase Inc.acquired by HniBofA Securitiesadvising the target$879Mstated$10.9M$1.5MDEFM14ANov 2025
Berry Corpacquired by CrcGuggenheim Securitiesadvising the target—$11M$2.5MDEFM14ANov 2025
Heidrick & Struggles International Inc.BofA Securitiesadvising the target$1.35Bstated$17.6M$2MDEFM14ANov 2025
Tiptree Inc.Barclaysadvising the target$1.65Bstated—$3MDEFM14AOct 2025
Tiptree Inc.BofA Securitiesadvising the target$1.65Bstated$9M—DEFM14AOct 2025
WideOpenWest, Inc.acquired by DigitalBridge and CrestviewCenterview Partnersadvising the special_committee$290Mstated$19.4M$2.5MDEFM14AOct 2025
ODP CorpJ.P. Morganadvising the target$842Mcomputed$23M$5MDEFM14AOct 2025
Sonnet BioTherapeutics Holdings, Inc.Chardanadvising the other$4.8Mstated$4M—DEFM14AOct 2025
Sonnet BioTherapeutics Holdings, Inc.Chardanadvising the other$4.8Mstated$9.64M—DEFM14AOct 2025
Pixelworks, Inc.Morgan Stanleyadvising the target—$5M—DEFM14AOct 2025
Hanesbrands Inc.acquired by GildanGoldman Sachsadvising the target—$47M—DEFM14AOct 2025
Hanesbrands Inc.acquired by GildanEvercoreadvising the target—$4.5M—DEFM14AOct 2025
Premier, Inc.acquired by Patient Square Capital FundGoldman Sachsadvising the target$2.32Bcomputed$29.6M—DEFM14AOct 2025
Premier, Inc.acquired by Patient Square Capital FundBofA Securitiesadvising the target$2.32Bcomputed$13.5M$2MDEFM14AOct 2025
Merus N.V.acquired by GenmabJefferiesadvising the target$7.34Bcomputed$90M$2MSC 14D9Oct 2025
Merus N.V.acquired by GenmabChestnutadvising the target$7.34Bcomputed$4M—SC 14D9Oct 2025
CureVac N.V.Goldman Sachsadvising the target—$19.7M$1MSC 14D9Oct 2025
Verint Systems Inc.Jefferiesadvising the target$1.24Bcomputed$31.8M$2.5MDEFM14AOct 2025
Verint Systems Inc.Evercoreadvising the target$1.24Bcomputed$3M—DEFM14AOct 2025
Metsera, Inc.acquired by PfizerGoldman Sachsadvising the target$5.25Bcomputed$30M—DEFM14AOct 2025
Metsera, Inc.acquired by PfizerBofA Securitiesadvising the target$5.25Bcomputed$10M—DEFM14AOct 2025
Metsera, Inc.acquired by PfizerGuggenheim Securitiesadvising the target$5.25Bcomputed$30M—DEFM14AOct 2025
Emeren Group LtdKrolladvising the special_committee—$320K$160KDEFM14AOct 2025
Norfolk Southern Corporationacquired by Union PacificMorgan Stanleyadvising the acquirer$20Bcomputed$52.5M$4MDEFM14AOct 2025
Norfolk Southern Corporationacquired by Union PacificWells Fargo Securitiesadvising the acquirer$20Bcomputed$52.5M$4MDEFM14AOct 2025
Norfolk Southern Corporationacquired by Union PacificBofA Securitiesadvising the target$20Bcomputed$130M$7.5MDEFM14AOct 2025
89bio, Inc.Centerview Partnersadvising the target_board$890Mcomputed$33M$1.5MSC 14D9Oct 2025
Pinnacle Financial Partners, Inc.Centerview Partnersadvising the target_board—$47.5M$5MDEFM14ASep 2025
Pinnacle Financial Partners, Inc.Morgan Stanleyadvising the other—$47.5M$5MDEFM14ASep 2025
Synovus Financial Corp.Morgan Stanleyadvising the target—$47.5M$5MDEFM14ASep 2025
Synovus Financial Corp.Centerview Partnersadvising the other—$47.5M$5MDEFM14ASep 2025
scPharmaceuticals Inc.Leerink Partnersadvising the target$285Mcomputed$8.8M$750KSC 14D9Sep 2025
Tourmaline Bio, Inc.acquired by NovartisLeerink Partnersadvising the target$1.23Bcomputed$30.8M$2MSC 14D9Sep 2025
Core Scientific, Inc.acquired by CoreWeaveMoelis & Companyadvising the target——$2MDEFM14ASep 2025
Core Scientific, Inc.acquired by CoreWeavePJT Partnersadvising the target—$10M$3MDEFM14ASep 2025
American Woodmark Corporationacquired by MasterBrandRothschildadvising the acquirer—$15M$3MDEFM14ASep 2025
American Woodmark Corporationacquired by MasterBrandJefferiesadvising the target—$13M—DEFM14ASep 2025
Elme Communitiesacquired by CortlandGoldman Sachsadvising the special_committee—$20.8M$2MDEFM14ASep 2025
Potbelly Corporationacquired by RaceTracPiper Sandleradvising the target$409Mcomputed$6.9M$1MSC 14D9Sep 2025
MeridianLink, Inc.acquired by CenterbridgeJ.P. Morganadvising the other$2.39Bstated$5M—DEFM14ASep 2025
MeridianLink, Inc.acquired by CenterbridgeCenterview Partnersadvising the target_board$2.39Bstated$29.4M$3MDEFM14ASep 2025
Augusta Gold Corp.NBFadvising the target—$1.75M$750KDEFM14ASep 2025
STAAR Surgical Companyacquired by AlconCitiadvising the target_board$1.39Bcomputed$30.6M$4MDEFM14ASep 2025
GSR III Acquisition Corp.acquired by Terra Innovatum GlobalERSharesadvising the target_board$475Mstated$75K$60KDEFM14ASep 2025
Aris Water Solutions, Inc.acquired by WesCitiadvising the target—$20M—DEFM14ASep 2025
Performant Healthcare, Inc.acquired by ContinentalTruist Securitiesadvising the target$715Mstated$23.7M$1MDEFM14ASep 2025
scPharmaceuticals Inc.Leerink Partnersadvising the target_board$285Mcomputed$8.8M$750KSC 14D9Sep 2025
Chart Industries, Inc.acquired by Baker HughesWells Fargo Securitiesadvising the target_board$10.1Bstated$55.8M—DEFM14ASep 2025
LAVA Therapeutics NVacquired by XomaLeerink Partnersadvising the target—$3M$1MDEFM14ASep 2025
ZimVie Inc.Centerview Partnersadvising the target_board$522Mcomputed$20M$7.5MDEFM14ASep 2025
Goldman Sachs Middle Market Lending Corp. IITruist Securitiesadvising the special_committee—$2.5M$750KDEFM14AAug 2025
Verona Pharma plcacquired by MerckCenterview Partnersadvising the target_board$9.11Bcomputed$113M$2MDEFM14AAug 2025

Showing the first 300 rows. Use the search box to narrow the list.

Coverage: public-company targets only, because private deals do not file fee disclosures. For private sales under $150M, the calculator uses advisor survey data instead. 57 extracted fee statements failed automated quote verification and are excluded.

Common questions

What percentage do investment banks charge to sell a company?

The disclosed share falls as the transaction gets larger. The bands above give the median and the middle half for each deal size, computed from 751 advisor fees stated in 660 merger proxies and tender-offer statements. A fee on a specific transaction is negotiated and can sit outside the band for its size.

Is the advisor's fee paid even if the deal does not close?

Usually only part of it. 515 of the advisor records state how much of the fee depends on closing, and the structure section above shows that share by deal size. The fairness opinion fee is the common exception: it is normally payable on delivery of the opinion whatever happens to the transaction.

What is a retainer or a monthly fee worth on these deals?

A merger proxy summarises the engagement rather than reproducing it, so it often does not say. Across 660 filings read in full, the engagement terms page counts how often a retainer, an expense cap, an indemnity or a credit of one fee against another is mentioned at all.

Where do these fees come from?

Each one is quoted from the filing that discloses it. A fee is included only when the sentence quoted for it appears word for word in the filing text and the amount appears in that sentence; 57 extracted statements failed that check and are excluded. Every row links to its filing.